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Abstract Low yield of adult adipose-derived multipotent stro-
mal cells (ASC) can limit autologous cell therapy in individuals
with minimal adipose tissue. In this study, ASC isolation was
optimized from approximately 0.2 g of feline epididymal adi-
pose tissue for a treatment dose of 106–107 ASCs/kg. The ASC
yield was determined for three digestions, 0.1 % collagenase in
medium for 30 min (Classic), 0.3 % collagenase in buffer for
30 min (New) and 0.3 % collagenase in buffer for 1 h (Hour).
After isolation by the new tissue digestion, continuously cul-
tured ASCs (fresh) and cells recovered and expanded after
cryostorage at P0 (revitalized) were characterized up to cell
passage (P) 5. Outcomes included CD9, CD29, CD44, CD90
and CD105 expression, cell doublings and doubling times,
fibroblastic, adipogenic and osteogenic colony forming unit
(CFU) frequency percentages and lineage-specific target gene
expression after induction. The New digestion had the highest
CFU yield, and about 7x106 ASCs/kg were available within
three cell passages (P2). Compared to earlier passages, target
surface antigen expression was lowest in fresh P5 cells, and
fresh and revitalized P3–5 cells had slower expansion. Fresh
and revitalized P1ASCs had higher CFU frequency percentages
and lineage-specific gene expression than P3. The New method
described in this study was most efficient for feline epididymal
ASC isolation and did not alter in vitro cell behavior. Fresh and
revitalized P0-P2 feline ASCs may be most effective for pre-
clinical and clinical trials. This study offers a potential option for
ASC isolation from limited adipose tissue resources across
species.
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Introduction
Adipose-derived multipotent stromal cells (ASCs) are an ap-
pealing cell option for numerous regenerative medicine ther-
apies due, in part, to culture expansion, multipotentiality,
immune privilege, trophic effects and higher in vitro prolifer-
ation compared to undifferentiated cells from bone marrow
[1–3]. While ASCs can be isolated from both white (WAT)
and brown (BAT) adipose tissue, WAT reportedly contains
more stromal vascular cells with a greater differentiation
potential [4–6]. Epididymal adipose tissue is one of the purest
sources of WAT [7]. According to the 2011–2012 American
Pet Products Association survey, 88% of privately owned cats
in the United States are spayed or neutered. Hence, feline
epididymal adipose tissue is a promising source of WAT
ASCs for feline therapeutic applications and intra-species
comparisons.
Existing reports support the potential therapeutic value of
feline MSCs, including neurogenic and cardiogenic capabilities
of adult bone marrow-derived multipotent stromal cells
(BMSCs)[8–11] and treatment of chronic kidney disease by
intra-renal injection of BMSCs and ASCs [12]. About 0.2–2 %
of cats in the United States suffer from diabetes mellitus,
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lymphoma or retinal disease [13–16]which also affect consider-
able numbers of other species, including humans [17–19]. There
are reports of cell-based therapies for these conditions in humans
and animals [17–21], but, to date, information surrounding
comparable therapies for the conditions in cats is scarce.
Quality and quantity of adipose tissue varies between sites
within and among individuals, human and animal [22,23].
Recent evidence also supports that orthotopic ASCs have the
greatest potential for site-specific tissue regeneration, some of
which have limited adipose tissue [24]. Isolation efficiency is
highly variable in both humans and animals [25,26]. The ASC
frequency in human subcutaneous adipose tissue cell isolates
is reported to range from 0.1 to 30 % [27–29] of the cell yield,
about 3 × 106 ASCs/ml [29] and 0.7–3 × 106 ASCs/g [30–32].
Reported therapeutic MSC doses range from 105 to 108 cells/
kg [12,21,33–37]. The highest ASC multipotentiality and
expansion rate occur up to about 10–20 cell doublings, and
senescence begins at 25 to 30 cell doublings, often corre-
sponding to about cell passage (P) 4 [38–40]. According to
results from other species, 0.5~2 × 106 nucleated cells can be
expanded from one gram of inguinal or epididymal adipose
tissue with a fibroblastic colony forming unit frequency-
fibroblastic (CFU-F) percentage of 1 to 10 % [29,41–43].
Hence, for most applications, adipose tissue from individual
cats must yield sufficient ASCs to provide a dose of 105–108
ASCs/kg within 3 to 4 cell passages (P2–3).
Prior to preclinical or clinical testing, it is imperative to
fully characterize ASC populations to meet standards
established by the International Society of Cell Therapy and
International Federation for Adipose Therapeutics and
Science that include cell phenotyping and confirmation of
trilineage differentiation by gene or protein expression
[44,45]. Lack of available antibodies and differences in cell
behavior among species require continued efforts to meet
these criteria in non-rodent animals [46]. Additionally,
species-specific information about ASC isolation and culture
expansion supports repeatable results with the greatest poten-
tial value for comparison among species [47]. This study
addresses these necessities by optimizing feline ASC isolation
and expansion to test the hypothesis that 106–107 ASCs/kg are
available from individual cat epididymal adipose tissue within
3 cell passages before and after ASC cryopreservation.
Materials and methods
Study design
Epididymal tissue was harvested during routine castration of
male domestic short hair cats (1.0±0.2 years, 2.9±0.3 kg, mean
± SEM) with a body condition score of 4–6 (range 1–9) [48].
For purposes of this study, the stromal vascular fraction (SVF) is
the primary cell isolate, and P0 is the first cell passage. Initially,
tissues from five cats were used to determine the ASC yield of
three different tissue digestion methods: 0.1 % collagenase in
Dulbecco’s modified Eagle’s medium (DMEM, Hyclone,
Logan, Utah, USA) for 30 min (Classic) and 0.3 % collagenase
in Kreb’s Ringer buffer for 30 min (New) or 1 h (Hour). Using
the New method of tissue digestion, cell expansion rates,
multipotentiality and surface marker expression were evaluated
for paired fresh and revitalized (cryopreserved) cells as follows:
cell percentages expressing CD9, CD29, CD44, CD90 or
CD105 (P0, 1, 3, 5, fresh; P1, 3, revitalized); cell doublings
(CD) and doubling times (DT) (P0-5, fresh; P1-P5, revitalized);
CFU -fibroblastic (F), adipocytic (Ad) and osteoblastic (Ob)
frequency percentages (SVF, P0, 1, 3, 5, fresh; P1, 3, revital-
ized); and lineage specific target gene expression with and
without differentiation media (adipogenic, osteogenic and
chondrogenic, P1, 3; fresh and revitalized). Additionally, mor-
phology of fresh cells (SVF, P0, 1 and 3) was evaluated. To
assess effects of cryopreservation, pairs of fresh and revitalized
ASCs harvested from the same cats were usedwithin assays. All
assays were performed in duplicate. Stromal vascular CFU-F
frequency percentages were determined from pooled tissue
harvested from 10 additional, unrelated male domestic short
hair cats to obtain adequate cell numbers.
Materials
ASC Isolation
Adipose tissue was isolated with sharp dissection, minced,
and digested in type I collagenase (33 ml/g adipose tissue,
Worthington Biochemical, Lakewood, NJ) within 4 h of har-
vest. Tissues from each cat (n=5) were divided into three
equal portions, and each portion was digested by one of three
methods: 1) 0.1 % type I collagenase in DMEM, 0.5 h, 60 rpm
(Classic); 2) 0.3 % type I collagenase in Kreb’s Ringer buffer
(KRB), 0.5 h, 1,000 rpm stirring (New); and 3) 0.3 % type I
collagenase in KRB, 1 h, 1,000 rpm stirring (Hour). Tissue
was added to collagenase solution in a 30 ml glass jar and
stirred with a stir bar at 37 °C for the New and Hour digestion
methods. For the Classic digestion method, digestionmixtures
within glass jars were agitated on a three-dimensional plate
shaker at 37 °C. Digests were filtered and then centrifuged
(260 g, 5 min). Resulting SVF pellets were resuspended in
5 ml red cell lysis buffer (0.16 mol/L NH4Cl, 0.01 mol/L
KHCO3, 0.01 % EDTA) followed by cell seeding in 10 mm
cell culture dishes in stromal medium (DMEM-Ham’s F12,
10 % fetal bovine serum (FBS, Hyclone), 1 % antibiotic/
antimycotic solution). Medium was refreshed after overnight
incubation under standard conditions (37 °C, 5 % CO2) and
then every 2–3 days. The total number of colonies with 20 or
more cells was determined after 7 days of culture. MSC
density was then calculated as colony number/adipose weight
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(g). The New method was selected to isolate ASCs for the
remainder of the study based on the highest number of
colonies/g tissue. When SVF cells reached 80 % confluence,
they were detached with 0.25 % trypsin and 0.1 % EDTA.
Cells were seeded at a density of 5 × 103 cells/cm2 for P0 and
all subsequent passages for evaluation of fresh cells. To pre-
pare revitalized cells, aliquots (5 × 105 cells) of P0 cells were
frozen in cryopreservation medium (80 % FBS, 10%DMEM,
10 % dimethyl sulfoxide) in liquid nitrogen for 30 days. Cells
were then revitalized and seeded at a density of 5 × 103 cells/
cm2 in stromal medium. Revitalized cells were subsequently
cultured and evaluated identically to fresh cells.
Immunophenotype
Cell aliquots (105–106 cells) were resuspended in 200 μl
phosphate buffered saline (PBS) containing 5 μl of antibodies
against feline antigens or validated for feline cross reactivity
(Table 1) and incubated for 30 min at room temperature (RT).
The cells were then washed with PBS and fixed with 4 %
paraformaldehyde (PFA). For CD9, CD29, CD44 and CD90,
indirect immunofluorescence was performed with goat anti-
mouse IgG-FITC. Cells without antibodies were used as neg-
ative autofluorescence control samples. Cellular fluorescence
was evaluated by flow cytometry (FACSCalibur and
CellQuest software, BD Biosciences, San Jose, California,
USA). Cell percentages expressing each antigen were deter-
mined by subtracting autofluorescence control from popula-
tion gated fluorescence.
Cell Expansion
P0 cells were seeded in 12-well plates and counted after 2, 4,
and 6 days of culture. Cell doublings and DTwere determined
with duplicate cultures and calculated with the formulae: CD =
ln(Nf/Ni)/ln(2); DT = CT/CD (Ni: initial cell number; Nf: final
cell number; CT = culture time) [49]. Day 2 and day 4 cell
counts were used as the initial number to calculate day 4 and 6
expansion rates, respectively.
Cell Morphology
Cells were cultured on glass coverslips in stromal medium for
7 days. They were washed with PBS, fixed in 4 % PFA for
20min, and permeabilized with 0.5% Triton-×100 for 20min.
Cell cytoskeleton was stained with Acti-stain™ 488 (1:150;
Cytoskeleton, Denver, CO) and nucleus with Hoechst dye
(1:2000). Slides were viewed with a fluorescent microscope
(DM4500B, Leica, Buffalo Grove, IL).
Trilineage Differentiation
After culture in stromal medium to 80 % confluence, cells were
transferred to adipogenic medium (minimum essential medium
alpha [α-MEM], 10 % rabbit serum, 10 % FBS, 10nM dexa-
methasone, 5 μg/mL insulin, 50 μM 5,8,11,14-eicosatetraynoic
acid [ETYA, Cayman, Ann Arbor, MI], 100 μM indomethacin)
for 10 days. They were then fixed with 4 % PFA and stained
with oil red O. Similarly, cells were cultured in osteogenic
medium (DMEM, 10 % FBS, 100 nM dexamethasone,
0.25 mM L-ascorbic acid) for 10 days and then in osteogenic
medium supplemented with 10nM β-glycerophosphate for an-
other 10 days. Theywere fixed in 70% ethanol and stainedwith
2 % alizarin red. For chondrogenesis, 5 × 105 cells were
centrifuged (200 × g, 5 min, 15 ml tubes) to form a pellet.
Pellets were cultured in chondrogenic medium (low glucose
DMEM-Ham’s F12, 3 % FBS, 1 % antibiotic/antimycotic so-
lution, 50μg/mL ascorbate phosphate, 100 nM dexamethasone,
40 μg/mL proline, 1 mM sodium pyruvate, 1 % ITS, 10 ng/mL
bone morphogenetic protein−6, 10 ng/mL transforming growth
factor- β1) for 21 days. At the end of the culture period, pellets
were formalin-fixed, paraffin-embedded, sectioned (5 μm) and
stained with alcian blue. Parallel cultures in stromal medium
were also performed to evaluate spontaneous differentiation.
Frequency of Multipotentiality
Limiting-dilution assays to determine CFU-F, -Ad and -Ob
frequency percentages were performed as previously reported
with changes indicated [38]. Due to low SVF ASC numbers,
samples were pooled from 10 unrelated cats, and 8 replicates
of 500, 250, 125, 63, 31 and 16 cells/well were seeded for
CFU-F. For all other passages, 8 replicates of 5 × 103, 2.5 ×
103, 1.25 × 103, 6.25 × 102, 3.12 × 102 or 1.56 × 102 cells/well
were seeded in 96-well plates and cultured in stromal medium
for 10 days. The CFU-F colonies were fixed with 4 % PFA
and stained with 0.1 % toluidine blue. For CFU-Ad and -Ob,
cells were cultured in lineage-specific differentiation media
and stained as described above. Wells were considered posi-
tive when there were ≥10 toluidine blue-stained colonies
(CFU-F), ≥10 oil red O-stained colonies (CFU-Ad), or ≥1
alizarin red-stained colonies (CFU-Ob). The CFU frequencies
were calculated as F = e-x (F: ratio of negative to total wells
Table 1 Fluorescence-activated cell sorting (FACS) antibodies
Antibody Label Target Species Manufacturer Cat No.
CD9 N/A Cat Serotec MCA1345
CD29 N/A Human BD Biosciences 610468
CD44 N/A Cat VMRD BAG40A
CD90 N/A Human eBiosciences 14–0909–80
CD105 PE Human eBiosciences 12–1057–41
IgG FITC Mouse Sigma-Aldrich F9006
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within a row, e: natural logarithm constant 2.71, x: CFU per
well). Based on Poisson’s distribution, F = 0.37 occurs when
the number of total cells plated (N) in a well contains a single
CFU. The CFU frequency percentage is reported as 100/N %.
Target Gene Expression
Total RNA was extracted from cells using TRIzol reagent
according to the manufacturer’s instructions. Quantity was
determined with a spect rophotometer (ND-100
spectrophotometer, NanoDrop Technologies, Wilmington,
DE), and 1 μg of tRNA was used for cDNA synthesis per
20 μl reaction (QuantiTect Reverse Transcription Kit,
Qiagen, Hilden, Germany). Feline-specific primers were
used for all reactions (Table 2), which were performed in
duplicate using SYBR Green (QuantiTect) and a real-time
polymerase chain reaction detection system (7900 Real-
Time PCR Detection System, Applied Biosystems,
Carlsbad, CA). The target gene fold change (2−ΔΔCt) of
cells cultured in induction media was determined relative
to parallel cells cultured in stromal medium using
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as
the reference gene.
Statistical Analysis
Results are presented as mean ± SEM. ANOVA models and
Turkey’s post hoc tests were performed to evaluate the effects
of isolation method on cell density (one-way) and cell passage
(P0–5) and preservation (fresh or revitalized; two-way) on cell
immunophenotype percentages, CD, DT, CFU frequency per-
centages andmRNA levels (P<0.05, SAS v9.3, SAS Institute,
Cary, NC). Variation between individual cats was included as
the error term for analysis of fixed effects.
Results
For all outcome measures, reported results are significant
unless otherwise indicated.
ASC Isolation
A mean of 0.2±0.03 g adipose tissue was harvested from each
cat. With tissues from 5 cats, the Hour and Classic isolation
methods yielded 3.8 and 1.6 colonies/g, respectively, which
were not significantly different. The New isolation method
had a higher yield of 126.3±33.9 colonies/g (Fig. 1). From
tissues of 14 cats, the mean ASC yield was 76.3±22.2
colonies/g, which was not significantly different from that
with 5 cats. At 80 % confluence, there were about 1 × 106
cells per 10 cm culture dish for P0-2.
Immunophenotype
The majority of P0, 1, 3, and 5 cells isolated with the New
tissue digestion method were CD9+, CD29+, CD44+, CD90+
and CD105+ (Fig. 2). Among passages, fresh cell P0 had
fewer CD105+ cells than P1, while P5 had fewer CD9+,
CD29+ and CD105+ cells than the majority of earlier pas-
sages (Fig. 3). Revitalized P1 had more CD9+ and CD105+
cells than P3, and fresh P3 had more CD9+ and CD105+ cells
than revitalized P3.
Cell Expansion
The overall CD for P0-5 fresh cells was 0.7±0.1 CD/days, and
the DT was 2.8±0.2 days/CD. Overall, cell expansion rates
tended to decrease as passages increased (Tables 3 and 4). For
fresh cells, P0 had higher CD than P1-5, and P1-2 had higher
CD than P3-5 (Table 3). Cell passages P0-3 had lower DT
Table 2 RT-PCR primer sequences
Lineage Gene Forward Primer (5’ – 3’) Reverse Primer (5’ – 3’)
Reference GAPDH GGTCATCCCAGAGCTGAATG AGCTTGACAAAGTGGTCATTG
Adipogenesis PPAR-γ GGGAGTTTCTAAAGAGCCTGAG GTCCTCAATGGGCTTCACATTCAGC
Leptin CCATCTTGGACAAACTCAGGAC GTTGAAGCTGTGCCAATCCG
Osteogenesis Col1α1 GACAAGGGTGAGACAGGCGAACAG CTTCTCTTGAGGTGGCTGGGGC
OPG GTCTCATTCGAGAAGAACCC CACAACCGCGTGTGCGAGTGC
Chondrogenesis Aggrecan GCAGTACACATCATAGGTCTC CATCGTGTTCCATTACAGAGC
Col2α1 CACAGATTATGTCGTCGCAGAGGAC CCAGACGCTGGTGCTGCTGACGC
Multipotentiality Sox2 GGAGGTACATGCTGATCATG CAGTACAACTCCATGACC
Nanog TTTGCTGTAACTGTATCTGGG CCAGGCTTCTATTCCTATCACCAG
PPAR-γ=peroxisome proliferator-activated receptor gamma; Col1=collagen type Iα1; OPG=osteoprotegerin; Col2α1=collagen type IIα1; Sox2=sex
determining region Y-box 2; Nanog=homeobox protein NANOG
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than P4 and 5 (Table 4). For revitalized cells, P1 and 2 had
higher CD than P3-5, P3 cells had higher CD than P4-5
(Table 3), P1-3 cells had lower DT than P4 and 5, and P4
had lower DT than P5 (Table 4). Fresh P4 cells had lower DT
than revitalized cells, and fresh P5 cells had higher CD and
lower DT than revitalized cells.
Cell Morphology
Five days after seeding, the majority of adherent SVF cells
had the spindle shaped morphology typical of ASCs, though
small, polygonal cells were apparent (Fig. 4A). The cell
population was more homogenous and organized at P0 and
1 with the same spindle shaped morphology (Figs. 4B, C). By
P3, the majority of cells were polygonal and poorly organized
(Fig. 4D).
Trilineage Differentiation
Cells maintained a fibroblastic-like appearance when cul-
tured in stromal media (Fig. 5A), and did not stain with
oil red O, ALP or alizarin red. In osteogenic medium with-
out β-glycerophosphate, cells expressed alkaline phospha-
tase (ALP) after 10 days of culture (Fig. 5B). Following the
addition of β-glycerophosphate, granular nodules formed
and stained with alizarin red (calcium deposition) after
21 days of culture (Fig. 5C). After about 4 days of culture
in adipogenic medium, cells became round, and, after
21 days, robust lipid droplets that stained with oil red O
were apparent (Fig. 5D). Cells were apparent within lacunae
in pellets cultured in chondrogenic medium after 21 days,
and unsulfated proteoglycans in the extra-cellular matrix
stained with alcian blue (Fig. 5E). Pellets cultured in stromal
medium did not have discernible lacunae or alcian blue
staining (Fig. 5F).
Frequency of Multipotentiality
The CFU frequency percentage is the percentage of cells
within a population that are capable of forming CFU-F, -Ad
or -Ob colonies. Due to low expansion rates after P3, revital-
ized P5 cells were not included in CFU assays. The SVFCFU-
F frequency was 1.6 % with the New tissue digestion method
(Table 5). Fresh P0 and 1 cells had higher CFU-F, −Ad, and -
Ob frequencies than P3 and 5. Revitalized P1 cells had higher
CFU-F, −Ad, and -Ob frequencies than P3. Also, fresh P3
cells had higher CFU-F and -Ob frequencies than revitalized
cells.
Target Gene Expression
Compared to P3, fresh and revitalized P1 cells had higher
mRNA levels of peroxisome proliferator-activated receptor
gamma (PPAR-γ) and leptin following culture in adipogenic
medium (Fig. 6A,B). After culture in osteogenic medium,
both fresh and revitalized P1cells had higher mRNA levels
of osteoprotegerin (OPG) and collagen 1α1 (col1α1) than
fresh and revitalized P3, respectively (Fig. 6C,D). After cul-
ture in chondrogenic medium, both fresh and revitalized P1
cells had higher collagen 2α1 (col2α1) than fresh and revital-
ized P3 (Fig. 6E,F), respectively. Following culture in osteo-
genic medium, both fresh and revitalized P1 had lower Nanog
levels than P3 (Fig. 6G). With culture in adipogenic medium,
revitalized P1 had lower levels of Nanog than P3, while fresh
P3 had lower Nanog levels than revitalized. Fresh and revi-
talized P1 had lower levels of Sox2 than P3 following culture
in either adipogenic or osteogenic medium (Fig. 6H).
Fig. 1 Feline epididymal adipose
tissue ASC yield (mean ± SEM,
n=5) from three different
digestion techniques (A). ASC
yield (n=14) from feline
epididymal adipose tissue using
the New digestion (B)
Fig. 2 Representative immunophenotype of P0 ASCs isolated from feline epididymal adipose tissue using the New tissue digestion method. The black
graphs represent stained cells and the green graphs autofluorescence
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Discussion
Mechanisms to generate therapeutic ASC doses from limited
tissue resources will increase options for orthotopic ASC
application and ASC therapies in individuals with limited
adipose deposits. Toward this goal, one of three adipose
digestion methods was found to yield sufficient feline ASCs
from minimal tissue to give a therapeutic dose within three
cell passages of fresh or cryopreserved cells, both of which
retained in vitro MSC characteristics. Decreasing MSC
immunophenotype, cell expansion and multipotentiality with
increasing passage suggests that early passages of fresh or
revitalized feline epididymal ASCs have the greatest potential
for therapeutic benefit. Study results contribute to continued
efforts surrounding isolation and in vitro characterization of
non-rodent ASCs for comparison among species and transla-
tional applications.
Standard protocols for ASC isolation, expansion and clinical
application are lacking despite promising therapeutic results in a
number of species including cats [12,21,35–37,50]. Cell isolates
are heterogeneous and can contain adipocyte precursors, mature
endothelial cells, hematopoietic cell populations and various
progenitor cells [51]. Significant variability among isolates can
reduce the ability to predict post-implantation behaviour [52].
Though individual variability among animals cannot be
avoided, standardized isolation and characterization techniques
for specific adipose deposits may significantly enhance the
predictability of ASC behaviour and efficacy following admin-
istration. The efficient, repeatable ASC isolation technique from
feline epididymal adipose tissue established in this investigation
is one option toward this goal.
Inconsistent cell expansion can contribute to differences
among cultured ASCs since extensively expanded cells are
technically “older” than those that have not been expanded as
much [53]. Though SVF colony numbers were relatively low
in this study, they were not significantly different among
animals. Further, cell seeding density was identical for all cell
passages. Adipose tissues were harvested from a relatively
homogenous population of young males in this investigation.
Hence, results reflect those of comparable cell populations
from a specific population. Decreased CD9+ and CD105+ cell
percentages in late cell passages parallel the observed reduc-
tions in multipotentiality based on CFU-Ad and -Ob frequen-
cy percentages and lineage-specific mRNA levels. Hence,
these changes are unlikely to be attributable to cell isolation.
Future investigations with cells isolated by the New method
from different ages and/or sex will continue to expand the
feline ASC knowledge base.
While the results of this study are currently limited toWAT
in male cats, it is possible that they may be similar for adipose
tissues accessible during other routine surgical procedures.
Adipose tissue available from excised castration tissue is
about a tenth of that typically harvested from other adipose
depots [54]. Despite this, a “dose” of cells was available
within three cell passages in this study using only plastic
affinity to select for ASCs [55]. This coupled with the knowl-
edge that cryopreserved cells maintain characteristics similar
to fresh ASCs confirms the feasibility of the New isolation
method to harvest cells for banking to capture the higher
density and greater multipotentiality of ASCs harvested at a
younger age [56–58]. The higher density of ASCs in WAT
likely contributed to the observed cell yield, so the efficiency
Fig. 3 Cell percentages (mean ± SEM) of P0, 1, 3 and 5 fresh a, P1 and 3 revitalized b, and P1 and 3 fresh and revitalized c ASCs positive for CD9,
CD29, CD44, CD90 or CD105. Columns with different letters within markers are significantly different from each other (P<0.05)
Table 3 Cell doublings (CDs/day) for fresh and revitalized feline epididymal ASCs isolated by the New digestion method (mean±SEM)
P0 P1 P2 P3 P4 P5
Fresh 1.3±0.1a 1.1±0.1b 0.9±0.1b 0.5±0.04c 0.3±0.02c 0.3±0.04*,c
Revitalized 1.1±0.1a 0.9±0.1a 0.5±0.03b 0.2±0.02c 0.1±0.01c
Values with asterisks within columns are significantly different between fresh and revitalized cells. Values with different lower-case letters among passages
within cell preservation (row) are significantly different (p<0.05)
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of the New digestion method will need to be independently
confirmed in brown and mixed adipose tissues [5,7].
The process of cell isolation from adipose tissue is a delicate
balance between adequate tissue disruption for effective cell
release without damage or destruction. Adipose tissue digests
typically include 0.1–0.3 % collagenase, and, for less than
0.5 g of tissue, concentrations as high as 1 %, are recommend-
ed [59]. To facilitate tissue disruption, constant shaking is
usually applied during the digestion process [28]. High colla-
genase concentrations can be cost prohibitive and result in cell
damage as can prolonged digestion times [59,60]. Alternative
enzymes like trypsin tend to have lower cell yields than colla-
genase [60].With a goal of optimizing cell releasewithout high
collagenase concentrations, enhanced mechanical tissue dis-
ruption by direct and indirect forces generated with a stir bar
was used in this study. Also to facilitate collagenase activity,
Kreb’s ringer buffer, which contains 4–5 fold fewer nutrients
than DMEM, was selected for the New and Hour collagenase
digestion solutions to avoid collagenous inhibition by DMEM
components like glucose and sulfhydryl and chelator-
containing amino acids [61–63]. The lower yield of the Hour
digestion may have been a consequence of both prolonged
collagenase digestion and mechanical trauma, but the more
aggressive tissue disruption over a shorter period was effective
in the New digestion.
The method used in this study to describe ASC yield, CFU/
g, provides a direct measure with which to estimate the
amount of tissue necessary for a desired cell yield. Cell yield
obtained with the New method is difficult to compare to other
studies since few report the number of CFU per unit tissue.
The CFU/g of this study was significantly lower than the
4,590 CFU/g lapin inguinal adipose tissue previously reported
[64]. A direct comparison is difficult, however, due to poten-
tial differences among digestion techniques, and CFU fre-
quency percentage is not provided. The CFU frequency per-
centage of the SVF isolated by the Newmethod was similar to
previous reports in other species [28,30,31,64]. Cell
immunophenotype, morphology, CD and DT and CFU-Ad
and -Ob frequency percentages of cells isolated with the New
digestion were similar to those reported for cats and other
species [1,11,12,38,41,49,54,55]. Given the high cell yield
compared to other digestion techniques, cell expansion fol-
lowing isolation by the New digestion method may provide
greater opportunities for therapeutic doses ofMSCs than other
options.
Differentiation media used in this study were optimized for
feline ASC based on existing knowledge from other species
[11,12,38]. Adipogenic medium contained ETYA and indo-
methacin which promote lipid droplet formation by PPAR-γ
activation, and rabbit serum, a component of canine and
Table 4 Doubling times (days/CD) for fresh and revitalized feline epididymal ASCs isolated by the New tissue digestion method (mean±SEM)
P0 P1 P2 P3 P4 P5
Fresh 1.7±0.2a 2.0±0.2a 2.5±0.2a 4.2±0.4a 6.9±0.6*,b 8.9±1.2*,b
Revitalized 1.9±0.1a 2.5±0.2a 4.3±0.4a 11.4±1.6b 18.2±1.2c
Values within columns with asterisks are significantly different between fresh and revitalized cells. Values with different lower-case letters within among
passages within cell preservation (columns) are significantly different (p<0.05)
Fig. 4 Fluorescent
photomicrographs of SVF a, P0
b, P1 c and P3 d feline pididymal
ASCs with cytoskeleton (actin,
green) and nuclear (DNA, blue)
staining (Acti-stain™ 488, actin;
Hoechst dye, DNA; 20×)
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equine ASC adipogenic medium that contains free fatty acids
for lipid production [11,65–67]. β-glycerophosphate was
added to osteogenic medium after 10 days of culture to avoid
colony delamination [68]. For chondrogenesis, bone morpho-
genetic protein-6 was added to enhance proteoglycan synthe-
sis as reported for equine MSCs [67,69,70]. The differentia-
tion media used in this study may be valuable for future non-
rodent ASC studies, especially in the area of in vitro feline and
other non-rodent mammal tissue generation.
Changes in lineage-specific gene expression was consistent
with previous reports following culture in differentiation me-
dium for fresh and revitalized cells in other species [38,54].
There were significant increases in P1 adipogenic (PPAR-γ,
leptin), osteogenic (Col1α1, OPG), and chondrogenic
(Col2α1) genes in corresponding differentiation media and
decreases in genes associated with multipotentiality (Sox2,
Nanog) following culture in osteogenesis and adipogenesis
medium. Changes in P3 fresh and revitalized ASC genetic
expression paralleled those of P1, but were decidedly lower.
This information is consistent with the CFU frequency per-
centage, cell morphology and cell expansion rate findings,
suggesting that ASC multipotentiality and expansion capacity
decreases with passage. Current information supports greater
potential for high passage bone marrow-derived multipotent
stromal cells to induce instant blood mediated inflammatory
reaction (IBMIR) when administered by systemic infusion
versus those derived from less ex vivo expansion in humans
[71]. A recent report on systemic allogeneic ASC administra-
tion for feline chronic kidney disease highlights significant
adverse reactions to high doses of cryopreserved cells
Fig. 5 Photomicrographs of feline ASCs after 10 days of culture in
stromal medium a, 5×; with alkaline phosphatase (ALP) staining indicat-
ing early stage osteogenesis after 10 days of culture in osteogenic medium
b, 10×; with alizarin red staining of calcium deposition after 21 days of
culture in osteogenic medium c, 5×; with oil red O lipid staining after
10 days of culture in adipogenic medium d, 40×; and showing early stage
chondrogenesis based on alcian blue staining of unsulfated proteoglycans
after 20 days of cell pellet culture in chondrogenic medium e, 64×. There
is no evidence of alcian blue staining in a cell pellet cultured in stromal
medium for 21 days f, 64×










0 Fresh 2.2±0.2a 0.3±0.02a 0.7±0.2a
1 Fresh 2.0±0.7a 0.3±0.08a 0.6±0.04a
Revitalized 1.9±0.4a 0.3±0.03a 0.5±0.1a
3 Fresh 0.1±0.01*,b 0.03±0.01b 0.1±0.01*,b
Revitalized 0.04±0.01b 0.02±0.01b 0.03±0.03b
5 Fresh 0.02±0.005c 0.002±0.002c 0.01±0.01c
CFU = colony forming unit; F = fibroblastic; Ad = adipocytic; Ob = osteoblastic. Values with asterisks are significantly different between fresh and
revitalized cells within passage and lineage. Values with different lower-case letters among passages within lineages and preservation (fresh or
revitalized) are significantly different (p<0.05)
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immediately after thawing [72]. The authors attributed the
reactions to IBMIR. In light of this information and the results
of this study, fresh and revitalized P0-P2 ASCs isolated by the
New tissue digestion method may be most suitable for future
preclinical and clinical trials.
Current research supports differences in multipotent capa-
bilities among MSC immunophenotypes [73–76]. Direct cor-
relations between CFU frequency percentages and cell surface
marker expression are beyond the scope of this study.
However, determination of the in vitro and in vivo behaviour
of specific feline ASC immunophenotypes will contribute to
the ability to confidently predict cell behaviour and thereby
identify patients and conditions that may derive the most
benefit from them. Future selection of ASCs by surface
marker expression may likely increase consistency in
in vitro and in vivo behaviour [52, 76].
Results from the present study demonstrate meaningful
numbers of ASCs that meet cell characterization standards
can be excised from limited adipose tissue in a non-rodent
mammal, the cat. Characteristics were maintained after cell
cryopreservation, confirming this mechanism to isolate ASCs
for later application to reduce cell expansion time, avoid tissue
harvest from sick or injured patients and for potential alloge-
neic application. Use of surface antigens and major histocom-
patibility markers to isolate homogenousASC populations is a
natural extension of the work reported here that may enhance
cell efficacy and reduce the potential for rejection or antigenic
stimulation [77] . The adipose tissue digestion method for
Fig. 6 Fold change (mean ±
SEM) of adipogenic (A,B),
osteogenic (C,D) and
chondrogenic (E,F) target gene
mRNA levels in feline
epididymal ASCs following
culture in adipogenic, osteogenic
and chondrogenic medium,
respectively, relative to parallel
stromal medium cultures. The
fold changes in genes associated
with multipotentiality (G,H)
relative to stromal medium
controls following culture in
adipogenic and osteogenic
medium are also shown. Columns
lower than the dotted line are
down regulated compared to
stromal controls (G,H). Columns
with different letters for a given
passage are significantly different
from each other. The P1 columns
with asterisks are significantly
different from P3 columns for
fresh and revitalized cells
(P<0.05)
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ASC isolation developed in this study may have wide appli-
cability for orthotopic ASC isolation and in patients with
limited adipose resources.
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